Teamwork Financial Advisors’s Biogen BIIB Stock Holding History

Teamwork Financial Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-16,950	Closed	-$4.53M	–	194
2022 Q3	$4.53M	Buy	+16,950	New	+$3.6M	0.98%	17

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Teamwork Financial Advisors's BIIB Position: Q4 2022 in Review

Teamwork Financial Advisors sold out of Biogen (BIIB) in Q4 2022, closing a stake of 16,950 shares — an estimated $4.53M sold.

Teamwork Financial Advisors first reported a position in BIIB in Q3 2022 and held it in 1 quarter. The position peaked at $4.53M in Q3 2022. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

Teamwork Financial Advisors reported no remaining Biogen position as of Q4 2022 after selling out during the quarter.
Teamwork Financial Advisors sold 16,950 Biogen shares in Q4 2022, an estimated $4.53M.
Teamwork Financial Advisors first reported a position in Biogen in Q3 2022 and held it in 1 quarter.
Teamwork Financial Advisors's Biogen position peaked at $4.53M in Q3 2022.
1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on Teamwork Financial Advisors's 13F filing for Q4 2022, filed 17 Jan 2023.